Cygnet Hospital Kewstoke
Weston-super-Mare, Somerset, BS22 9UZ, United Kingdom
NCT Number: NCT07261033
The purpose of this research is for the multi-disciplinary team at an inpatient psychiatric hospital to investigate more innovative ways to engage service users in order to promote wellbeing and emotional regulation. In particular, there is a focus on engaging patients who do not routinely engage with the Psychology Team. As such, we are aiming to explore the effectiveness of Equine Assisted Psychotherapy (EAP) with the service users on a specialist Personality Disorder ward.
EAP is the deliberate inclusion of an equine (e.g. horse, alpaca) amongst a therapy team to improve patient outcomes. This therapy team includes a mental health professional and certified equine specialist, along with equine(s) and client(s). EAP can offer specific psychotherapeutic treatment goals such as addressing trauma and emotion dysregulation. The presence of an equine removes the need for verbal communication, which allows for non-verbal approaches that support self-development; identifying and discussing the feelings, emotions and behaviours generated through interaction with the horse. The presence of equine also provides a unique opportunity for traumatised individuals to build trust with other sentient beings that value connection, safety, and trust.
These specific psychotherapeutic treatment goals are especially relevant for those with a diagnosis of Emotionally Unstable Personality Disorder (EUPD). Service users with EUPD present with complex mental health difficulties, often with problems with emotional regulation, attachment, and self-harm.
This research will use a qualitative, single arm design in which all participants (inpatients who have received an Emotionally Unstable personality Disorder diagnosis) engage in a novel psychotherapeutic intervention (6 sessions of Equine-Assisted Psychotherapy). Their experiences of this psychotherapeutic intervention will be explored using semi-structured interviews. Researchers and participants will collaborate in using Thematic Analysis to analyse the content of these interviews.
This study is active but is not currently recruiting participants.
Notify Me18 year–65 year
Female
Interventional
Not applicable
Weston-super-Mare, Somerset, BS22 9UZ, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants will attend 6 half-day sessions of Equine-Assisted Psychotherapy. This is psychotherapy between the professional(s) and the client(s) which takes place in the presence of an equine (e.g. horse, alpaca). This will be conducted at a specialist clinic by a member of their facilitator team. There will also be hospital staff on-hand to provide support if needed, but hospital staff will not be involved in the therapy directly. The therapy will involve a group session (1 hour and 15 minutes long), and individual sessions (30 minutes per participant).
Time frame: From enrolment to 1 week after end of last Equine-Assisted Psychotherapy session. This should be a maximum of 8 weeks in total.
This will be measured via semi structured interview questions and the thematic analysis of participants' responses. It will focus on whether participants notice a difference in how they are able to regulate their emotions following therapeutic intervention and, if so, what that change is and why participants think that change has happened.
Time frame: From enrolment to 1 week after end of last Equine-Assisted Psychotherapy session. This should be a maximum of 8 weeks in total.
This will be measured via semi structured interview questions and the thematic analysis of participants' responses. It will focus on whether participants notice a difference in how they are able to connect with others following therapeutic intervention and, if so, what that change is and what they think caused it.
Time frame: From first therapy session to one week after the last Equine-Assisted Psychotherapy session. Up to 7 weeks in total.
This will be measured via semi structured interview questions and the thematic analysis of participants' responses. It will focus on how the participants felt about the therapy e.g. what they liked/disliked about it and which aspects were meaningful to them.
Time frame: From first therapy session to one week after the last Equine-Assisted Psychotherapy session. Up to 7 weeks in total.
This will be measured via semi structured interview questions and the thematic analysis of participants' responses. It will focus on how the participants felt this therapy compared to other therapies they have experience e.g. In what ways is it better/worse?
Time frame: From start of first Equine-Assisted Psychotherapy session to end of last Equine-Assisted Psychotherapy session. The Equine-Assisted Psychotherapy runs for 6 weeks in total.
The number of participants that withdraw from the intervention.
Time frame: From start of first Equine-Assisted Psychotherapy session to end of last Equine-Assisted Psychotherapy session. These run for 6 weeks in total.
The number of Equine-Assisted Psychotherapy sessions each participant attends.
Cygnet Healthcare
Other
Exploring the Effectiveness of Equine Assisted Psychotherapy on the Emotional Regulation and Mental Wellbeing of Service Users in an Inpatient Setting Who Have Received a Diagnosis of Emotionally Unstable Personality Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05381649
Emotionally Unstable Personality Disorder, Borderline Type
Livingston, United Kingdom
View Trial DetailsNCT07082777
Anxiety Disorders, Asperger Syndrome
Aarhus C, Denmark
View Trial DetailsNCT07585955
Attention Deficit and Disruptive Behavior Disorders, Conduct Disorder
Valencia, Spain
View Trial DetailsNCT06693089
Behavior, Behavioral Symptoms
Verona, Italia, Italy
View Trial Details